CN106220599A - 一种槲皮素赖氨酸共无定形物 - Google Patents
一种槲皮素赖氨酸共无定形物 Download PDFInfo
- Publication number
- CN106220599A CN106220599A CN201610594378.8A CN201610594378A CN106220599A CN 106220599 A CN106220599 A CN 106220599A CN 201610594378 A CN201610594378 A CN 201610594378A CN 106220599 A CN106220599 A CN 106220599A
- Authority
- CN
- China
- Prior art keywords
- quercetin
- lysine
- amorphous substance
- altogether
- anhydride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610594378.8A CN106220599B (zh) | 2016-07-26 | 2016-07-26 | 一种槲皮素赖氨酸共无定形物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610594378.8A CN106220599B (zh) | 2016-07-26 | 2016-07-26 | 一种槲皮素赖氨酸共无定形物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106220599A true CN106220599A (zh) | 2016-12-14 |
CN106220599B CN106220599B (zh) | 2018-05-01 |
Family
ID=57533579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610594378.8A Active CN106220599B (zh) | 2016-07-26 | 2016-07-26 | 一种槲皮素赖氨酸共无定形物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106220599B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109589323A (zh) * | 2018-12-11 | 2019-04-09 | 福州乾正药业有限公司 | 神经酸与egcg的固体分散体组合物及其制备方法和应用 |
CN113304113A (zh) * | 2021-05-31 | 2021-08-27 | 桂林医学院 | 一种提高槲皮素溶出的共无定型固体分散体及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101429185A (zh) * | 2007-11-09 | 2009-05-13 | 中国医学科学院药物研究所 | 槲皮素两种晶型物质、其制法和其药物组合物与用途 |
CN103058976A (zh) * | 2007-11-09 | 2013-04-24 | 中国医学科学院药物研究所 | 槲皮素α晶型物质、其制法和其药物组合物与用途 |
CN103980276A (zh) * | 2014-05-26 | 2014-08-13 | 中国药科大学 | 槲皮素咖啡因共晶 |
-
2016
- 2016-07-26 CN CN201610594378.8A patent/CN106220599B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101429185A (zh) * | 2007-11-09 | 2009-05-13 | 中国医学科学院药物研究所 | 槲皮素两种晶型物质、其制法和其药物组合物与用途 |
CN103058976A (zh) * | 2007-11-09 | 2013-04-24 | 中国医学科学院药物研究所 | 槲皮素α晶型物质、其制法和其药物组合物与用途 |
CN103980276A (zh) * | 2014-05-26 | 2014-08-13 | 中国药科大学 | 槲皮素咖啡因共晶 |
Non-Patent Citations (1)
Title |
---|
郭慧慧,等: "共无定形药物—新型单相无定形二元体系", 《化学进展》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109589323A (zh) * | 2018-12-11 | 2019-04-09 | 福州乾正药业有限公司 | 神经酸与egcg的固体分散体组合物及其制备方法和应用 |
CN113304113A (zh) * | 2021-05-31 | 2021-08-27 | 桂林医学院 | 一种提高槲皮素溶出的共无定型固体分散体及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN106220599B (zh) | 2018-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102911179A (zh) | 埃克替尼盐酸盐晶型、药物组合物和用途 | |
JP4654187B2 (ja) | テクトリゲニンのイソフラボン誘導体、その調製、および有効成分としてこれを含む抗ウィルス剤 | |
CN106860465B (zh) | 一种天麻素化合物及其制剂 | |
CN107311915A (zh) | 一种水杨酸有机药物共晶及其制备方法 | |
CN102584780A (zh) | 一种蓝萼甲素衍生物及其制备方法和应用 | |
CN106220599A (zh) | 一种槲皮素赖氨酸共无定形物 | |
CN102321134B (zh) | 一种化合物、其制备方法及用途 | |
CN104513290B (zh) | 雷醇内酯衍生物及其应用 | |
CN103910616A (zh) | 一种姜黄素衍生物及其制备与应用 | |
CN102391336B (zh) | 一种化合物、其制备方法及用途 | |
CN103980276A (zh) | 槲皮素咖啡因共晶 | |
CN110156700A (zh) | 吉非替尼与水杨酸共晶体 | |
CN107540661A (zh) | 作为egfr抑制剂的苯胺嘧啶化合物的结晶 | |
JP2018512429A (ja) | フィリゲニングルクロン酸誘導体、その調製方法及びその応用 | |
Circioban et al. | Kinetics of heterogeneous-induced degradation for artesunate and artemether | |
CN109010348A (zh) | 一种拉西地平-螺内酯共无定形固体分散体及其制备 | |
CN106554339A (zh) | 一种异黄酮衍生物及其制备方法和用途 | |
CN109675050A (zh) | 以喜树碱为母核的类似物与非甾体抗炎药物的偶联物及其制备与应用 | |
CN115124531A (zh) | 一类4-氮杂色胺酮芳香硫醚衍生物、制备方法及应用 | |
CN111217825B (zh) | 4-o-氨丙基土甘草a衍生物及其制备及应用 | |
WO2018014368A1 (zh) | 一种水溶性靛红衍生物及其制备方法与应用 | |
CN107320735A (zh) | 一种他莫昔芬组合物及其制剂 | |
Zivdar et al. | Derivatization of Curcumin and the Effect of Resultant Derivatives on BRC-9 Breast Cancer Cells | |
CN106632373A (zh) | 一种岩白菜素的d晶型固体物质及其制备方法与用途 | |
Zhang et al. | A drug–drug cocrystal and a co-amorphous form, prepared from honokiol and ligustrazine, inspired by Chinese patent medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Quercetin-lysine coamorphous substance Effective date of registration: 20200417 Granted publication date: 20180501 Pledgee: Bank of Communications Limited Shenzhen Branch Pledgor: NYCRIST PHARMATECH Ltd. Registration number: Y2020980001576 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20221128 Granted publication date: 20180501 Pledgee: Bank of Communications Limited Shenzhen Branch Pledgor: NYCRIST PHARMATECH Ltd. Registration number: Y2020980001576 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Quercetin lysine co amorphous Effective date of registration: 20221213 Granted publication date: 20180501 Pledgee: Bank of Communications Limited Shenzhen Branch Pledgor: NYCRIST PHARMATECH Ltd. Registration number: Y2022980027119 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |